CorVel Corp. 10-Q Summary: Quarter Ended September 30, 1997
Business Context and Reporting Period
This Form 10-Q covers CorVel Corporation for the quarter and six months ended September 30, 1997. CorVel provides managed care services, primarily in the workers' compensation sector, including patient management and provider network services. The company is incorporated in Delaware and headquartered in Irvine, California.
Key Financial Metrics
| Metric | Three Months Ended Sept 30, 1997 | Six Months Ended Sept 30, 1997 |
|---|---|---|
| Revenues | $34,683,000 | $68,707,000 |
| Net Income | $2,381,000 | $4,656,000 |
| Diluted EPS | $0.55 | $1.07 |
| Gross Margin | 18.7% | 18.8% |
| Operating Margin | 11.1% | 10.9% |
| Cash from Operations | Filing text does not provide a clear value for the three-month period | $4,735,000 |
| Cash and Equivalents (Sept 30, 1997) | $11,203,000 | |
| Total Debt | None reported | |
| Working Capital | $26,080,000 (Current Assets $37.2M - Current Liabilities $11.1M) |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 17% year-over-year for the quarter ($4.96M increase) and 15% for the six-month period ($9.1M increase).
- Revenue Drivers: Growth was driven by a 28% increase in patient management revenue (quarter) and a 5% increase in provider revenues. Case management revenue grew to $19.6M for the quarter.
- Profitability: Net income rose 14% for the quarter and 13% for the six-month period compared to the prior year.
- Expense Trends: General and administrative (G&A) expenses as a percentage of revenue increased from 7.1% to 7.6% for the quarter, attributed to system installation costs (WAN). Gross margins remained stable, improving slightly due to productivity gains offset by pricing pressures.
- Capital Allocation: The company repurchased $6.6 million of its own common stock during the six-month period, reducing cash balances and increasing treasury stock.
Outlook, Risks, and Management Commentary
- Liquidity: Management believes current cash ($11.2M) and anticipated internal funds are sufficient for the next 12 months. Net working capital decreased by $2.4M primarily due to stock repurchases.
- Regulatory Risks: Significant exposure to state licensing laws for medical review services and evolving managed care regulations. Potential legislative reforms, such as combining workers' compensation with traditional health plans, could adversely affect demand.
- Competition: Facing increased competition from insurers, HMOs, and PPOs entering the workers' compensation market. Legislative changes allowing employers to designate health plans for workers' comp claims may intensify this competition.
- Legal Liability: Potential exposure to litigation regarding medical treatment recommendations, though the company maintains professional liability insurance.
- Growth Strategy: Focus on internal growth and potential acquisitions. Expansion into the group health market has seen moderate success but faces mature competition.
Investor Verification Checklist
- Verify the sustainability of the 28% growth in patient management revenue and the impact of new national contracts.
- Monitor the trend of G&A expenses as a percentage of revenue, specifically regarding technology infrastructure costs.
- Assess the impact of state-specific regulatory changes on licensing costs and operational scope.
- Review the company's cash burn rate relative to the $6.6M stock repurchase program and future capital needs.
- Confirm the status of any pending litigation mentioned in the "normal course of business" disclosure.